Axsome Therapeutics, Inc.

AXSM·NasdaqGM·Healthcare
Compare
166.00−2.35 (−1.40%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours166.000.00 (0.00%)Oct 12, 4:56 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close168.35
Open169.41
Day range165.02170.80
52-week range120.12260.19
Off day high−2.81%
Off 52-week high−36.20%
Volume662.98K
Avg. volume (3M)710.90K
Market cap8.70B
EPS (TTM)-3.74
Forward P/E35.59
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.85
Shares outstanding52.38M
Short interest9.79% of float
Earnings dateNov 2, 2026
Analyst target283.63
Profit margin−24.68%

Against its peers

Compare in full ›
AXSM ACAD PRAX JAZZ IONS HRMY
Market cap 8.70B 3.34B 7.02B 14.07B 7.26B 2.23B
P/E (TTM) — 8.7 — 14.9 — 12.3
Forward P/E 35.6 21.5 -26.9 8.4 -39.3 5.5
Price/book 104.2 2.6 5.2 2.9 16.4 2.2
Dividend yield — — — — — —
1-year change +34.39% −3.24% +396.48% +61.62% −35.85% +52.81%
Today −1.40% −1.87% −3.26% −0.76% −3.56% −5.09%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Axsome Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Acadia Pharmaceuticals Inc.ACAD · Biotechnology 3.34B 19.41 −1.87%
Praxis Precision Medicines, Inc.PRAX · Biotechnology 7.02B 251.38 −3.26%
Jazz Pharmaceuticals plcJAZZ · Biotechnology 14.07B 216.75 −0.76%
Ionis Pharmaceuticals, Inc.IONS · Biotechnology 7.26B 43.67 −3.56%
Harmony Biosciences Holdings, Inc.HRMY · Biotechnology 2.23B 38.23 −5.09%
Arrowhead Pharmaceuticals, Inc.ARWR · Biotechnology 8.58B 60.73 −3.22%
BridgeBio Pharma, Inc.BBIO · Biotechnology 12.85B 65.75 +0.61%
Alto Neuroscience, Inc.ANRO · Biotechnology 947.70M 24.15 −0.90%

Also based in New York, New York, then elsewhere in New York.

Company Mkt cap Price Today
JPMorgan Chase & Co.JPM · New York, NYOdds 888.63B 334.30 +0.39%
Morgan StanleyMS · New York, NYOdds 298.44B 190.02 0.00%
The Goldman Sachs Group, Inc.GS · New York, NYOdds 260.29B 893.95 −0.15%
Citigroup Inc.C · New York, NYOdds 221.29B 131.92 +1.76%
American Express CompanyAXP · New York, NYOdds 210.38B 311.53 +1.09%
BlackRock, Inc.BLK · New York, NYOdds 176.11B 1,083.92 +0.14%
Verizon Communications Inc.VZ · New York, NY 177.74B 42.78 +2.71%
Pfizer Inc.PFE · New York, NYOdds 161.87B 28.40 +0.42%

The stocks whose daily moves over the past year went most closely with Axsome Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Cytokinetics, IncorporatedCYTK · Correlation 0.40 8.73B 62.79 −0.19%
BridgeBio Pharma, Inc.BBIO · Correlation 0.34 12.85B 65.75 +0.61%
Ascendis Pharma A/SASND · Correlation 0.32 14.94B 227.00 −0.97%
CG Oncology, Inc.CGON · Correlation 0.31 5.60B 63.13 −1.08%
TG Therapeutics, Inc.TGTX · Correlation 0.31 8.46B 55.27 −0.18%

What visitors to Axsome Therapeutics's page also look at.

Company Mkt cap Price Today
TG Therapeutics, Inc.TGTX 8.46B 55.27 −0.18%
Madrigal Pharmaceuticals, Inc.MDGL 10.79B 467.16 −0.97%
Aurinia Pharmaceuticals IncAUPH 2.20B 16.55 −0.60%
BridgeBio Pharma, Inc.BBIO 12.85B 65.75 +0.61%
Iovance Biotherapeutics, Inc.IOVA 6.60B 14.56 −0.41%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All AXSM news ›
Pulse 2.0·Positive

TriGemX Bio Raises $94 Million To Advance Phase 3 Migraine Program

TriGemX Bio raised $94 million in financing co-led by The Column Group, TCGX, and Viking Global Investors to advance development of elismetrep, its investigational treatment for acute migraine. The company was formerly known as Kallyope…

The Motley Fool·

Is Axsome Therapeutics a Buy on the Dip?

Axsome Therapeutics (AXSM +0.27%) has seen its stock price climb over the past few years -- and for good reason. The company has progressively launched new products, confirming its expertise in the neuroscience space. This biotech aims to…

From articles in the 4Search news index.

In the news

17mentions in 30 days
15with it in the headline
Positivesentiment

Mentioned with

Axsome Therapeutics, Inc.11Pfizer7Eli Lilly6Morgan Stanley6Amgen Inc.5Cormedix Therapeutics5Eli Lilly and Company5Gilead Sciences5

People in the coverage

Cantor10Sara Appino10Kim Johansen9Tourette9Danessa Lincoln8H.c Wainwright8

Themes

Healthcare9Earnings8Financial8Lly6Therapeutics6Provides5Quarter5Reports5

Most coverage from

  1. fool.com5
  2. manilatimes.net2
  3. quiverquant.com2
  4. theglobeandmail.com2
  5. globenewswire.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.